A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone

DMM Disease Models and Mechanisms

Volumn 7, Issue 2, 2014, Pages 299-309

  Thibaudeau, Laure ^a   Taubenberger, Anna V ^a,b   Holzapfel, Boris M ^a,c   Quent, Verena M ^d   Fuehrmann, Tobias ^a,e   Hesami, Parisa ^a   Brown, Toby D ^a   Dalton, Paul D ^a   Power, Carl A ^f   Hollier, Brett G ^a,g   Hutmacher, Dietmar W ^a,g,h,i  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

^h GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bone metastasis; Breast cancer; Humanized xenograft model; Melt electrospinning; Osteotropism; Tissue engineering

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; BONE TUMOR; BREAST TUMOR; FEMALE; HUMAN; MOUSE; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SCID MOUSE; SECONDARY; TISSUE ENGINEERING; TUMOR MICROENVIRONMENT; XENOGRAFT;

ANIMALS; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HETEROGRAFTS; HUMANS; MICE; MICE, SCID; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; TISSUE ENGINEERING; TUMOR MICROENVIRONMENT;

EID: 84894292115     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.014076     Document Type: Article

References (65)

1. Asahina, I., Sampath, T. K., Nishimura, I. and Hauschka, P. V. (1993). Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J. Cell Biol. 123, 921-933.
2. Brown, T. D., Slotosch, A., Thibaudeau, L., Taubenberger, A., Loessner, D., Vaquette, C., Dalton, P. D. and Hutmacher, D. W. (2012). Design and fabrication of tubular scaffolds via direct writing in a melt electrospinning mode. Biointerphases 7, 1-16.
3. Canon, J. R., Roudier, M., Bryant, R., Morony, S., Stolina, M., Kostenuik, P. J. and Dougall, W. C. (2008). Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis. Clin. Exp. Metastasis 25, 119-129.
4. Chai, Y. C., Roberts, S. J., Desmet, E., Kerckhofs, G., van Gastel, N., Geris, L., Carmeliet, G., Schrooten, J. and Luyten, F. P. (2012). Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers. Biomaterials 33, 3127-3142.
5. Chambers, A. F., Groom, A. C. and MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563-572.
6. Chan, C. K., Chen, C. C., Luppen, C. A., Kim, J. B., DeBoer, A. T., Wei, K., Helms, J. A., Kuo, C. J., Kraft, D. L. and Weissman, I. L. (2009). Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 457, 490-494.
7. El-Mabhouh, A. A., Nation, P. N., Kaddoura, A. and Mercer, J. R. (2008). Unexpected preferential brain metastases with a human breast tumor cell line MDAMB- 231 in BALB/c nude mice. Vet. Pathol. 45, 941-944.
8. Eyckmans, J., Roberts, S. J., Schrooten, J. and Luyten, F. P. (2010). A clinically relevant model of osteoinduction: a process requiring calcium phosphate and BMP/Wnt signalling. J. Cell. Mol. Med. 14, 1845-1856.
9. Gundle, R., Joyner, C. J. and Triffitt, J. T. (1995). Human bone tissue formation in diffusion chamber culture in vivo by bone-derived cells and marrow stromal fibroblastic cells. Bone 16, 597-601.
10. Harms, J. F., Welch, D. R., Samant, R. S., Shevde, L. A., Miele, M. E., Babu, G. R., Goldberg, S. F., Gilman, V. R., Sosnowski, D. M., Campo, D. A. et al. (2004). A small molecule antagonist of the α(v)β3 integrin suppresses MDA-MB-435 skeletal metastasis. Clin. Exp. Metastasis 21, 119-128.
11. Henriksen, G., Breistoøl, K., Bruland, O. S., Fodstad, Oø. and Larsen, R. H. (2002). Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model. Cancer Res. 62, 3120-3125.
12. Hiraga, T., Ito, S. and Nakamura, H. (2013). Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. Cancer Res. 73, 4112-4122.
13. Holzapfel, B. M., Thibaudeau, L., Hesami, P., Taubenberger, A., Holzapfel, N. P., Mayer-Wagner, S., Power, C., Clements, J., Russell, P. and Hutmacher, D. W. (2013). Humanised xenograft models of bone metastasis revisited: novel insights into species-specific mechanisms of cancer cell osteotropism. Cancer Metastasis Rev. 32, 129-145.
14. Hutmacher, D. W., Horch, R. E., Loessner, D., Rizzi, S., Sieh, S., Reichert, J. C., Clements, J. A., Beier, J. P., Arkudas, A., Bleiziffer, O. et al. (2009). Translating tissue engineering technology platforms into cancer research. J. Cell. Mol. Med. 13, 1417-1427.
15. Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A. and Massagué, J. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549.
16. Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A. et al. (2005). VEGFR1- positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827.
17. Kawai, M., Hattori, H., Yasue, K., Mizutani, H., Ueda, M., Kaneda, T. and Hoshino, T. (1994). Development of hemopoietic bone marrow within the ectopic bone induced by bone morphogenetic protein. Blood Cells 20, 191-199 discussion 200-201
18. Kempen, D. H., Lu, L., Hefferan, T. E., Creemers, L. B., Heijink, A., Maran, A., Dhert, W. J. and Yaszemski, M. J. (2010). Enhanced bone morphogenetic protein- 2-induced ectopic and orthotopic bone formation by intermittent parathyroid hormone (1-34) administration. Tissue Eng. Part A 16, 3769-3777.
19. Khalili, P., Arakelian, A., Chen, G., Singh, G. and Rabbani, S. A. (2005). Effect of Herceptin on the development and progression of skeletal metastases in a xenograft model of human breast cancer. Oncogene 24, 6657-6666.
20. Khanna, C. and Hunter, K. (2005). Modeling metastasis in vivo. Carcinogenesis 26, 513-523.
21. Kozlow, W. and Guise, T. A. (2005). Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J. Mammary Gland Biol. Neoplasia 10, 169-180.
22. Krebsbach, P. H., Gu, K., Franceschi, R. T. and Rutherford, R. B. (2000). Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum. Gene Ther. 11, 1201-1210.
23. Kuperwasser, C., Dessain, S., Bierbaum, B. E., Garnet, D., Sperandio, K., Gauvin, G. P., Naber, S. P., Weinberg, R. A. and Rosenblatt, M. (2005). A mouse model of human breast cancer metastasis to human bone. Cancer Res. 65, 6130-6138.
24. Lam, C. X. F., Hutmacher, D. W., Schantz, J.-T., Woodruff, M. A. and Teoh, S. H. (2009a). Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J. Biomed. Mater. Res. 90A, 906-919.
25. Lam, P., Yang, W., Amemiya, Y., Kahn, H., Yee, A., Holloway, C. and Seth, A. (2009b). A human bone NOD/SCID mouse model to distinguish metastatic potential in primary breast cancers. Cancer Biol. Ther. 8, 1010-1017.
26. Le Gall, C., Bellahcène, A., Bonnelye, E., Gasser, J. A., Castronovo, V., Green, J., Zimmermann, J. and Clézardin, P. (2007). A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden. Cancer Res. 67, 9894-9902.
27. Li, Y., Tondravi, M., Liu, J., Smith, E., Haudenschild, C. C., Kaczmarek, M. and Zhan, X. (2001). Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res. 61, 6906-6911.
28. Ling, L. J., Wang, S., Liu, X. A., Shen, E. C., Ding, Q., Lu, C., Xu, J., Cao, Q. H., Zhu, H. Q. and Wang, F. (2008). A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone. Chin. Med. J. (Engl.) 121, 1980-1986.
29. Liu, S., Goldstein, R. H., Scepansky, E. M. and Rosenblatt, M. (2009). Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res. 69, 8742-8751.
30. Moreau, J. E., Anderson, K., Mauney, J. R., Nguyen, T., Kaplan, D. L. and Rosenblatt, M. (2007). Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Cancer Res. 67, 10304-10308.
31. Nemeth, J. A., Harb, J. F., Barroso, U., Jr, He, Z., Grignon, D. J. and Cher, M. L. (1999). Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res. 59, 1987-1993.
32. Nöth, U., Osyczka, A. M., Tuli, R., Hickok, N. J., Danielson, K. G. and Tuan, R. S. (2002). Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J. Orthop. Res. 20, 1060-1069.
33. Ooi, L. L., Zheng, Y., Zhou, H., Trivedi, T., Conigrave, A. D., Seibel, M. J. and Dunstan, C. R. (2010). Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis. Bone 47, 795-803.
34. Ooi, L. L., Zheng, Y., Stalgis-Bilinski, K. and Dunstan, C. R. (2011). The bone remodeling environment is a factor in breast cancer bone metastasis. Bone 48, 66-70.
35. Pathi, S. P., Lin, D. D. W., Dorvee, J. R., Estroff, L. A. and Fischbach, C. (2011). Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis. Biomaterials 32, 5112-5122.
36. Pearson, H. B. and Pouliot, N. (2012). Modeling metastasis in vivo. In: Madame Curie Bioscience Database [Internet]. Austin TX: Landes Bioscience. http://www.ncbi.nlm.nih.gov/books/NBK100378/
37. Psaila, B. and Lyden, D. (2009). The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer 9, 285-293.
38. Rangarajan, A. and Weinberg, R. A. (2003). Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat. Rev. Cancer 3, 952-959.
39. Reichert, J. C., Quent, V. M. C., Burke, L. J., Stansfield, S. H., Clements, J. A. and Hutmacher, D. W. (2010). Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment. Biomaterials 31, 7928-7936.
40. Retting, K. N., Song, B., Yoon, B. S. and Lyons, K. M. (2009). BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 136, 1093-1104.
41. Rutherford, R. B., Moalli, M., Franceschi, R. T., Wang, D., Gu, K. and Krebsbach, P. H. (2002). Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng. 8, 441-452.
42. Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Piersanti, S., Saggio, I., Tagliafico, E., Ferrari, S., Robey, P. G., Riminucci, M. et al. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324-336.
43. Sasaki, A., Boyce, B. F., Story, B., Wright, K. R., Chapman, M., Boyce, R., Mundy, G. R. and Yoneda, T. (1995). Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res. 55, 3551-3557.
44. Sasano, Y., Ohtani, E., Narita, K., Kagayama, M., Murata, M., Saito, T., Shigenobu, K., Takita, H., Mizuno, M. and Kuboki, Y. (1993). BMPs induce direct bone formation in ectopic sites independent of the endochondral ossification in vivo. Anat. Rec. 236, 373-380.
45. Scepansky, E., Goldstein, R. and Rosenblatt, M. (2001). Preclinical orthotopic and intracardiac injection models of human breast cancer metastasis to bone and their use in drug discovery. Current Protocols in Pharmacology 52, 14.18.1-14.18.23.
46. Schuster, J., Zhang, J. and Longo, M. (2006). A novel human osteoblast-derived severe combined immunodeficiency mouse model of bone metastasis. J. Neurosurg. Spine 4, 388-391.
47. Shiozawa, Y., Pedersen, E. A., Havens, A. M., Jung, Y., Mishra, A., Joseph, J., Kim, J. K., Patel, L. R., Ying, C., Ziegler, A. M. et al. (2011). Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J. Clin. Invest. 121, 1298-1312.
48. Shtivelman, E. and Namikawa, R. (1995). Species-specific metastasis of human tumor cells in the severe combined immunodeficiency mouse engrafted with human tissue. Proc. Natl. Acad. Sci. USA 92, 4661-4665.
49. Sieh, S., Lubik, A. A., Clements, J. A., Nelson, C. C. and Hutmacher, D. W. (2010). Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model. Organogenesis 6, 181-188.
50. Singh, H., Teoh, S. H., Low, H. T. and Hutmacher, D. W. (2005). Flow modelling within a scaffold under the influence of uni-axial and bi-axial bioreactor rotation. J. Biotechnol. 119, 181-196.
51. Song, J., Kiel, M. J., Wang, Z., Wang, J., Taichman, R. S., Morrison, S. J. and Krebsbach, P. H. (2010). An in vivo model to study and manipulate the hematopoietic stem cell niche. Blood 115, 2592-2600.
52. Sun, Q. Y. and Schatten, H. (2006). Role of NuMA in vertebrate cells: review of an intriguing multifunctional protein. Front. Biosci. 11, 1137-1146.
53. Suva, L. J., Washam, C., Nicholas, R. W. and Griffin, R. J. (2011). Bone metastasis: mechanisms and therapeutic opportunities. Nat. Rev. Endocrinol. 7, 208-218.
54. Taubenberger, A. V., Quent, V. M., Thibaudeau, L., Clements, J. A. and Hutmacher, D. W. (2013). Delineating breast cancer cell interactions with engineered bone microenvironments. J. Bone Miner. Res. 28, 1399-1411.
55. Tormin, A., Li, O., Brune, J. C., Walsh, S., Schütz, B., Ehinger, M., Ditzel, N., Kassem, M. and Scheding, S. (2011). CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 117, 5067-5077.
56. Tortelli, F., Tasso, R., Loiacono, F. and Cancedda, R. (2010). The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials 31, 242-249.
57. Travlos, G. S. (2006). Normal structure, function, and histology of the bone marrow. Toxicol. Pathol. 34, 548-565.
58. Tsumaki, N. and Yoshikawa, H. (2005). The role of bone morphogenetic proteins in endochondral bone formation. Cytokine Growth Factor Rev. 16, 279-285.
59. Ulrich, D., van Rietbergen, B., Laib, A. and Rüegsegger, P. (1999). The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 25, 55-60.
60. Vaquette, C., Ivanovski, S., Hamlet, S. M. and Hutmacher, D. W. (2013). Effect of culture conditions and calcium phosphate coating on ectopic bone formation. Biomaterials 34, 5538-5551.
61. Yang, W., Lam, P., Kitching, R., Kahn, H. J., Yee, A., Aubin, J. E. and Seth, A. (2007). Breast cancer metastasis in a human bone NOD/SCID mouse model. Cancer Biol. Ther. 6, 1295-1300.
62. Yi, B., Williams, P. J., Niewolna, M., Wang, Y. and Yoneda, T. (2002). Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res. 62, 917-923.
63. Yoneda, T., Williams, P. J., Hiraga, T., Niewolna, M. and Nishimura, R. (2001). A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J. Bone Miner. Res. 16, 1486-1495.
64. Yonou, H., Yokose, T., Kamijo, T., Kanomata, N., Hasebe, T., Nagai, K., Hatano, T., Ogawa, Y. and Ochiai, A. (2001). Establishment of a novel species- and tissuespecific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res. 61, 2177-2182.
65. Zheng, Y., Zhou, H., Fong-Yee, C., Modzelewski, J. R., Seibel, M. J. and Dunstan, C. R. (2008). Bone resorption increases tumour growth in a mouse model of osteosclerotic breast cancer metastasis. Clin. Exp. Metastasis 25, 559-567.